Search Results for "Hyaluronic Acid Dna Damage"
Original Source: A hypothetical correlation between hyaluronic acid gel and development of cutaneous metaplastic synovial cyst.
ABSTRACT: Thousands of patients receive hyaluronic acid filler injections, and the effects are generally considered acceptable. The acid rarely causes cutaneous reactions, which are only occasionally reported in the literature. The aim of the present work is to analyze a clinical case that has never been reported in the literature to our knowledge. This case is of a 26-year-old woman who presented with a cyst in the infrazygomatic region that was injected with non-animal stabilized hyaluronic acid at anothe...
Matching Channels
Matching News
PolyRemedy introduces HealSmart Hyaluronic Acid Dressing
PolyRemedy, a US-based provider of wound management systems, has added Hyaluronic Acid (HA) to its HealSmart Antimicrobial Dressings.
Novozymes starts commercial supply of new and improved hyaluronic acid from Q7 cGMP facility
Novozymes Biopharma, part of Novozymes A/S, has announced the first shipment of the company’s Bacillus-derived hyaluronic acid, Hyasis, from its newly inaugurated manufacturing facility in China.
Hyaluronic Acid Effective for Older Patients With TMJ OA
Adding injections of hyaluronic acid to arthrocentesis in temporomandibular joint osteoarthritis appears to be less effective for patients younger than 45 years. Medscape Medical News
Hyaluronic acid injections ineffective for knee osteoarthritis
Clinical question Is viscosupplementation with hyaluronic acid injection effective in decreasing pain in patients with knee osteoarthritis?
Hyaluronic acid injections ‘discouraged’ for knee osteoarthritis
Intra-articular injections of hyaluronic acid offer a small, clinically irrelevant decrease in osteoarthritis knee pain at the risk for serious adverse events, suggest the results of a review and meta...
Alchemia's oncology subsidiary proposes IPO
Audeo Oncology Inc., the newly formed U.S. subsidiary of Alchemia Ltd. (ASX:ACL), said it plans to raise up to $60 million in an IPO on NASDAQ underwritten by Leerink and Oppenheimer. The subsidiary i...
Audeo Oncology Inc. (San Francisco, Calif.) amended its IPO and now plans to sell 3.3 million shares at $14-$16 per share. At the mid-point of $15, Audeo would raise $48.8 million be valued at $162.6...
Matching PubMed Articles
A review on the use of hyaluronic acid in tympanic membrane wound healing.
Introduction: Tympanic membrane perforation represents a significant morbidity, especially if it occurs during a child's speech and language development. Recently, there has been an increased interes...
ABSTRACT: Thousands of patients receive hyaluronic acid filler injections, and the effects are generally considered acceptable. The acid rarely causes cutaneous reactions, which are only occasionally...
Assessment of new hyaluronic acid assays and their impact on FibroMeter scores.
We compared three hyaluronic acid (HA) assays and analyzed the impact of their variations on FibroMeter scores.
Soft tissue fillers (STFs) together with botulinum toxin have profoundly improved our possibilities to rejuvenate the face and other parts of human body. Among many types of STFs currently used for es...
Purpose: The aim of this study was to determine the role of gangliosides in pathogenic mechanisms of thyroid-associated ophthalmopathy (TAO). Methods: We investigated the gangliosides profile and mRNA...
